Cite
HARVARD Citation
Gonçalves, J. et al. (n.d.). P664 SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis. Journal of Crohn's and colitis. pp. S451-S452. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gonçalves, J. et al. (n.d.). P664 SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis. Journal of Crohn's and colitis. pp. S451-S452. [Online].